Olukemi Olugemo - Jun 3, 2024 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Role
Chief Medical Officer
Signature
/s/ Shelby Walker, Attorney-in-fact
Stock symbol
KRRO
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/4/2024, 07:12 PM
Previous filing
May 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRRO Stock Option (Right to Buy) Award $0 +65K $0.00 65K Jun 3, 2024 Common Stock 65K $50.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as to 25% of the shares on May 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.